title: BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer.
abstract: BRCA1 mutations and estrogen use are risk factors for the development of breast cancer. Recent work has identified estrogen receptors localized at the plasma membrane that signal to cell biology. We examined the impact of BRCA1 on membrane estrogen and growth factor receptor signaling to breast cancer cell proliferation. MCF-7 and ZR-75-1 cells showed a rapid and sustained activation of extracellular signal-related kinase (ERK) in response to estradiol (E2) that was substantially prevented by wild-type (wt) but not mutant BRCA1. The proliferation of MCF-7 cells induced by E2 was significantly inhibited by PD98059, a specific ERK inhibitor, or by dominant negative ERK2 expression and by expression of wt BRCA1 (but not mutant BRCA1). E2 induced the synthesis of cyclins D1 and B1, the activity of cyclin-dependent kinases Cdk4 and CDK1, and G(1)/S and G(2)/M cell cycle progression. The intact tumor suppressor inhibited all of these. wt BRCA1 also inhibited epidermal growth factor and insulin-like growth factor I-induced ERK and cell proliferation. The inhibition of ERK and cell proliferation by BRCA1 was prevented by phosphatase inhibitors and by interfering RNA knockdown of the ERK phosphatase, mitogen-activated kinase phosphatase 1. Our findings support a novel tumor suppressor function of BRCA1 that is relevant to breast cancer and identify a potential interactive risk factor for women with BRCA1 mutations.
authors.affiliation: Division of Endocrinology, Veterans Affairs Medical Center, Long Beach, California 90822, USA.
authors.forename: Mahnaz
authors.initials: M
authors.lastname: Razandi
authors.forename: Ali
authors.initials: A
authors.lastname: Pedram
authors.forename: Eliot M
authors.initials: EM
authors.lastname: Rosen
authors.forename: Ellis R
authors.initials: ER
authors.lastname: Levin
mesh_terms: D019313:BRCA1 Protein / Q000235:genetics / Q000502:physiology*; D001943:Breast Neoplasms / Q000209:etiology* / Q000473:pathology; D002455:Cell Division; D045744:Cell Line, Tumor; D004958:Estradiol / Q000494:pharmacology; D006801:Humans; D008565:Membrane Proteins; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D009154:Mutation / Q000502:physiology; D011960:Receptors, Estrogen / Q000037:antagonists & inhibitors* / Q000502:physiology; D017978:Receptors, Growth Factor / Q000037:antagonists & inhibitors* / Q000502:physiology; D015398:Signal Transduction; D014162:Transfection
chemical_list: D019313:BRCA1 Protein; D008565:Membrane Proteins; D011960:Receptors, Estrogen; D017978:Receptors, Growth Factor; D004958:Estradiol; D020928:Mitogen-Activated Protein Kinases